Organigram Global Inc. (OGI) income statement
OGINasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Sep 30, 2025Last filing: 40-F on Dec 16, 2025Score 4/30
$0.68−0.03 (-4.29%)
Close on Nov 18, 2026Market cap $90.98MP/E –Yield –
Organigram Global Inc. income statement
Ratios
Latest available, balances at Sep 30, 2025
Profitability, FY2025
- Gross margin
- 34.8%
- Operating margin
- -5.9%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 2.26
- Debt to equity
- –
- Debt to assets
- 0.0%
- Cash to current liabilities
- 66.3%
Valuation
- P/E ratio
- –
- Price to sales
- 0.50
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?